However, clinical studies have shown that among MG patients, 85% are anti-AChR antibody-positive MG (AChR-MG), 6% are anti-MuSK antibody-positive MG (MuSK-MG) (34), and 2% are LRP4-MG (35, 36). Here, MUSK is linked to myasthenia gravis.